Medicines in China’s National Health Insurance System

AvChina Development Research Foundation

Häftad, Engelska, 2024

Del i serien Routledge Studies on the Chinese Economy

646 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Fler format och utgåvor

E-bok

760 kr

E-bok

760 kr

Inbunden

2 739 kr

Beskrivning

This book presents the findings of systematic research into the healthcare medicine management policies of China. In-depth comprehensive research has been carried out, targeting multiple issues of particular importance in healthcare medicine management, such as the purchasing, pricing, payment, usage, and the function of commercial healthcare insurance in medical payment. The book goes on to put forward policy advice regarding the aforementioned issues.

Produktinformation

Utgivningsdatum:2024-05-27
Mått:156 x 234 x 26 mm
Vikt:453 g
Format:Häftad
Språk:Engelska
Serie:Routledge Studies on the Chinese Economy
Antal sidor:492
Förlag:Taylor & Francis Ltd
ISBN:9781032351131

Utforska kategorier

Finansiering inom Ekonomi och Ledarskap

Mer om författaren

China Development Research Foundation (CDRF) is a public foundation initiated and led by the Development Research Center of the State Council (DRC) on November 27, 1997. Its mission is to advance good governance and public policy to promote economic development and social progress. Financial support for the Foundation is provided by donations from Chinese and international patrons. Funding is used to support policy research, publications, leadership training, development forums, and academic exchanges, as well as rewarding individuals who make great contribution in policy consulting or related areas of academic research and funding other social philanthropic activities that fit with the goal of the foundation.

Innehållsförteckning

1. Research on dynamic mechanisms for adjusting the national list of reimbursable drugs 2. Research on drug procurement mechanisms 3. Research on drug pricing mechanisms 4. Research on drug payment and usage 5. Research on the role of commercial health insurance in reimbursing drug costs 6. Research on drug pricing mechanisms in other countries